Summary

The global hydrocephalus shunts market is witnessing sustained growth, fueled by the increasing incidence of neurological disorders, expanding geriatric population, and technological innovations in neurosurgical devices. Hydrocephalus—marked by abnormal accumulation of cerebrospinal fluid (CSF) within the brain cavities—continues to affect both pediatric and elderly populations, creating long-term demand for shunt-based interventions. According to new findings by Fairfield Market Research, the hydrocephalus shunts market is anticipated to grow at a CAGR of 4.19% during the forecast period from 2022 to 2032. The market, which stood at a valuation of US$ 330.8 million in 2025, is projected to reach approximately US$ 441 million by the end of 2032.

Market Insights

Hydrocephalus shunts are widely used to manage cerebrospinal fluid buildup in the brain, particularly in pediatric cases and older adults. The rising adoption of programmable valves and antisiphon devices is transforming the treatment Analysis, offering greater precision and safety in fluid drainage. These advancements are not only improving patient outcomes but also attracting the attention of neurosurgeons and healthcare institutions globally.

Hydrocephalus affects an extensive age spectrum—children under five years of age and adults over sixty are particularly vulnerable. While developed regions such as North America and Europe experience rising cases due to their aging demographics, countries in Africa and Eastern Asia continue to report high birth rates, resulting in a steady incidence of pediatric hydrocephalus.

Market Drivers

Several underlying factors are propelling the hydrocephalus shunts market forward:

• Growing Geriatric Population: Aging populations across developed nations are increasingly susceptible to conditions like normal pressure hydrocephalus, fueling the need for long-term surgical interventions.

• Increased Prevalence of Neurological Disorders: Rising cases of traumatic brain injuries, tumors, and infections that affect cerebrospinal fluid dynamics are boosting the demand for CSF management systems.

• Technological Innovation: The introduction of adjustable pressure valves and antisiphon mechanisms is making shunt systems safer and more effective. Key manufacturers are also developing advanced neurosurgical catheters to reduce device failures.

• Healthcare Infrastructure Development: Emerging economies are experiencing improvements in medical infrastructure, making surgical interventions more accessible and driving market expansion in previously underserved areas.

Business Opportunities

The hydrocephalus shunts market is expected to witness lucrative opportunities, particularly in low- and middle-income countries. According to global epidemiological studies, Sub-Saharan Africa alone reports over 225,000 new pediatric hydrocephalus cases annually. With increasing international support and healthcare funding, these regions are becoming focal points for market development.

Additionally, major medical device firms are targeting high-growth regions like Asia-Pacific through joint ventures, local manufacturing, and R&D investments to tap into rising demand and expand their global footprint.

Regional Analysis

• North America: The United States dominates the global hydrocephalus shunts market, contributing a major share due to the presence of leading medical device companies and a high prevalence of traumatic brain injuries. With over 280,000 hospitalizations due to TBIs annually, the demand for hydrocephalus shunting procedures remains high.

• Europe: Countries such as the UK, Germany, and France are driving regional market growth due to well-established healthcare systems and growing awareness of cerebral disorders. The UK, in particular, benefits from its strong medical tourism sector and early adoption of advanced surgical equipment.

• Asia-Pacific: Japan and South Korea are emerging as highly attractive markets, thanks to substantial government investments in healthcare infrastructure and medical device innovation. In Japan, public-private partnerships and R&D efforts are helping address the growing social burden of neurological diseases. South Korea is witnessing increased adoption of programmable shunts, further supporting market growth.

• Latin America & Africa: These regions represent untapped potential. Despite facing infrastructural challenges, international healthcare programs and developmental aid are creating a supportive environment for the expansion of shunt procedures and related devices.

Key Players

The global hydrocephalus shunts market is characterized by the presence of several established players focused on continuous innovation and strategic partnerships. Leading companies are investing in R&D to develop safer, longer-lasting shunt systems and non-invasive diagnostic solutions.

Prominent market participants include:

• B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG)

• Medtronic Plc

• Integra LifeSciences Holdings Corporation

• Natus Medical Incorporated

• Spiegelberg GmbH & Co. KG

• Ophysa

• HpBio Próteses, Inc.

• KANEKA MEDIX CORP.

• Desu Medical

Innovative advancements are shaping competition. For example, Rhaeos, Inc. has developed a non-invasive temperature sensor, FlowSense, to monitor shunt performance—receiving breakthrough device status from the FDA. Similarly, research conducted by MIT in 2020 proposes new catheter designs to reduce blockage and enhance performance, which may redefine future product development standards.

Recent Developments

• In 2021, the National Institute of Neurological Disorders and Stroke (NINDS) awarded US$ 14 million to study hydrocephalus therapies.

• Researchers at Penn State announced the development of HydroFix—a novel surgical device designed to minimize the risks associated with traditional shunts.

• Several startups and academic institutions are actively exploring bio-compatible and smart-shunt technologies to enhance CSF management and minimize revision surgeries.

Market Restraints

Despite positive growth indicators, the hydrocephalus shunts market faces certain limitations. During the COVID-19 pandemic, elective surgeries were delayed or canceled, significantly affecting the demand for shunt devices. Moreover, potential complications such as infections, shunt failures, and the emergence of alternative, non-shunt treatments pose risks to long-term market expansion.

Additionally, a shortage of trained neurosurgeons and inconsistent access to healthcare in lower-income regions can hinder adoption rates. Safety concerns around existing devices may also restrain consumer confidence and adoption without sufficient clinical validation.

Market Segmentation

By Type:

• Ventriculo-Peritoneal

• Ventriculo-Atrial

• Ventriculo-Pleural

• Lumbo-Peritoneal

By Product:

• Hydrocephalus Valves

• Hydrocephalus Catheters

• Neuronavigation Systems

• Others

By Age Group:

• Pediatric

• Adults

By End User:

• Hospitals

• Ambulatory Surgical Centers

• Others

By Region:

• North America

• Europe

• Asia-Pacific

• Middle East & Africa

• South America

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Hydrocephalus Shunts Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Hydrocephalus Shunts Market Outlook, 2019-2032
3.1. Global Hydrocephalus Shunts Market Outlook, by Type, Value (US$ Mn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Ventriculo-Peritoneal
3.1.1.2. Ventriculo-Atrial
3.1.1.3. Ventriculo-Pleural
3.1.1.4. Lumbo-Peritoneal
3.2. Global Hydrocephalus Shunts Market Outlook, by Product, Value (US$ Mn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Hydrocephalus Valves
3.2.1.2. Hydrocephalus Catheters
3.2.1.3. Neuronavigation Systems
3.2.1.4. Others
3.3. Global Hydrocephalus Shunts Market Outlook, by Age Group, Value (US$ Mn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Paediatric
3.3.1.2. Adults
3.4. Global Hydrocephalus Shunts Market Outlook, by End User, Value (US$ Mn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. Hospitals
3.4.1.2. Ambulatory Surgical Centers
3.4.1.3. Others
3.5. Global Hydrocephalus Shunts Market Outlook, by Region, Value (US$ Mn), 2019-2032
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Hydrocephalus Shunts Market Outlook, 2019-2032
4.1. North America Hydrocephalus Shunts Market Outlook, by Type, Value (US$ Mn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Ventriculo-Peritoneal
4.1.1.2. Ventriculo-Atrial
4.1.1.3. Ventriculo-Pleural
4.1.1.4. Lumbo-Peritoneal
4.2. North America Hydrocephalus Shunts Market Outlook, by Product, Value (US$ Mn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Hydrocephalus Valves
4.2.1.2. Hydrocephalus Catheters
4.2.1.3. Neuronavigation Systems
4.2.1.4. Others
4.3. North America Hydrocephalus Shunts Market Outlook, by Age Group, Value (US$ Mn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Paediatric
4.3.1.2. Adults
4.4. North America Hydrocephalus Shunts Market Outlook, by End User, Value (US$ Mn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. Hospitals
4.4.1.2. Ambulatory Surgical Centers
4.4.1.3. Others
4.5. North America Hydrocephalus Shunts Market Outlook, by Country, Value (US$ Mn), 2019-2032
4.5.1. Key Highlights
4.5.1.1. U.S. Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
4.5.1.2. U.S. Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
4.5.1.3. U.S. Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
4.5.1.4. U.S. Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
4.5.1.5. Canada Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
4.5.1.6. Canada Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
4.5.1.7. Canada Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
4.5.1.8. Canada Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Hydrocephalus Shunts Market Outlook, 2019-2032
5.1. Europe Hydrocephalus Shunts Market Outlook, by Type, Value (US$ Mn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Ventriculo-Peritoneal
5.1.1.2. Ventriculo-Atrial
5.1.1.3. Ventriculo-Pleural
5.1.1.4. Lumbo-Peritoneal
5.2. Europe Hydrocephalus Shunts Market Outlook, by Product, Value (US$ Mn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Hydrocephalus Valves
5.2.1.2. Hydrocephalus Catheters
5.2.1.3. Neuronavigation Systems
5.2.1.4. Others
5.3. Europe Hydrocephalus Shunts Market Outlook, by Age Group, Value (US$ Mn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Paediatric
5.3.1.2. Adults
5.4. Europe Hydrocephalus Shunts Market Outlook, by End User, Value (US$ Mn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Ambulatory Surgical Centers
5.4.1.3. Others
5.5. Europe Hydrocephalus Shunts Market Outlook, by Country, Value (US$ Mn), 2019-2032
5.5.1. Key Highlights
5.5.1.1. Germany Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
5.5.1.2. Germany Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
5.5.1.3. Germany Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
5.5.1.4. Germany Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
5.5.1.5. U.K. Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
5.5.1.6. U.K. Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
5.5.1.7. U.K. Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
5.5.1.8. U.K. Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
5.5.1.9. France Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
5.5.1.10. France Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
5.5.1.11. France Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
5.5.1.12. France Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
5.5.1.13. Italy Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
5.5.1.14. Italy Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
5.5.1.15. Italy Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
5.5.1.16. Italy Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
5.5.1.17. Turkey Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
5.5.1.18. Turkey Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
5.5.1.19. Turkey Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
5.5.1.20. Turkey Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
5.5.1.21. Russia Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
5.5.1.22. Russia Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
5.5.1.23. Russia Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
5.5.1.24. Russia Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
5.5.1.25. Rest of Europe Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
5.5.1.26. Rest of Europe Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
5.5.1.27. Rest of Europe Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
5.5.1.28. Rest of Europe Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Hydrocephalus Shunts Market Outlook, 2019-2032
6.1. Asia Pacific Hydrocephalus Shunts Market Outlook, by Type, Value (US$ Mn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Ventriculo-Peritoneal
6.1.1.2. Ventriculo-Atrial
6.1.1.3. Ventriculo-Pleural
6.1.1.4. Lumbo-Peritoneal
6.2. Asia Pacific Hydrocephalus Shunts Market Outlook, by Product, Value (US$ Mn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Hydrocephalus Valves
6.2.1.2. Hydrocephalus Catheters
6.2.1.3. Neuronavigation Systems
6.2.1.4. Others
6.3. Asia Pacific Hydrocephalus Shunts Market Outlook, by Age Group, Value (US$ Mn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Paediatric
6.3.1.2. Adults
6.4. Asia Pacific Hydrocephalus Shunts Market Outlook, by End User, Value (US$ Mn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. Institutional sale
6.4.1.1.1. Hospitals
6.4.1.1.2. Ambulatory Surgical Centers
6.4.1.1.3. Others
6.4.1.2. Retail Sales
6.4.1.2.1. Retails Pharmacies
6.4.1.2.2. Drug Stores
6.4.1.2.3. Mail Order Pharmacies
6.4.1.2.4. Retail Stores
6.4.1.2.5. Online Sales
6.5. Asia Pacific Hydrocephalus Shunts Market Outlook, by Country, Value (US$ Mn), 2019-2032
6.5.1. Key Highlights
6.5.1.1. China Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
6.5.1.2. China Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
6.5.1.3. China Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
6.5.1.4. China Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
6.5.1.5. Japan Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
6.5.1.6. Japan Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
6.5.1.7. Japan Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
6.5.1.8. Japan Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
6.5.1.9. South Korea Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
6.5.1.10. South Korea Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
6.5.1.11. South Korea Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
6.5.1.12. South Korea Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
6.5.1.13. India Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
6.5.1.14. India Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
6.5.1.15. India Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
6.5.1.16. India Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
6.5.1.17. Southeast Asia Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
6.5.1.18. Southeast Asia Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
6.5.1.19. Southeast Asia Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
6.5.1.20. Southeast Asia Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
6.5.1.21. Rest of Asia Pacific Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
6.5.1.22. Rest of Asia Pacific Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
6.5.1.23. Rest of Asia Pacific Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
6.5.1.24. Rest of Asia Pacific Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Hydrocephalus Shunts Market Outlook, 2019-2032
7.1. Latin America Hydrocephalus Shunts Market Outlook, by Type, Value (US$ Mn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Ventriculo-Peritoneal
7.1.1.2. Ventriculo-Atrial
7.1.1.3. Ventriculo-Pleural
7.1.1.4. Lumbo-Peritoneal
7.2. Latin America Hydrocephalus Shunts Market Outlook, by Product, Value (US$ Mn), 2019-2032
7.2.1.1. Hydrocephalus Valves
7.2.1.2. Hydrocephalus Catheters
7.2.1.3. Neuronavigation Systems
7.2.1.4. Others
7.3. Latin America Hydrocephalus Shunts Market Outlook, by Age Group, Value (US$ Mn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Paediatric
7.3.1.2. Adults
7.4. Latin America Hydrocephalus Shunts Market Outlook, by End User, Value (US$ Mn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Hospitals
7.4.1.2. Ambulatory Surgical Centers
7.4.1.3. Others
7.5. Latin America Hydrocephalus Shunts Market Outlook, by Country, Value (US$ Mn), 2019-2032
7.5.1. Key Highlights
7.5.1.1. Brazil Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
7.5.1.2. Brazil Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
7.5.1.3. Brazil Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
7.5.1.4. Brazil Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
7.5.1.5. Mexico Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
7.5.1.6. Mexico Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
7.5.1.7. Mexico Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
7.5.1.8. Mexico Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
7.5.1.9. Argentina Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
7.5.1.10. Argentina Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
7.5.1.11. Argentina Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
7.5.1.12. Argentina Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
7.5.1.13. Rest of Latin America Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
7.5.1.14. Rest of Latin America Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
7.5.1.15. Rest of Latin America Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
7.5.1.16. Rest of Latin America Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Hydrocephalus Shunts Market Outlook, 2019-2032
8.1. Middle East & Africa Hydrocephalus Shunts Market Outlook, by Type, Value (US$ Mn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Ventriculo-Peritoneal
8.1.1.2. Ventriculo-Atrial
8.1.1.3. Ventriculo-Pleural
8.1.1.4. Lumbo-Peritoneal
8.2. Middle East & Africa Hydrocephalus Shunts Market Outlook, by Product, Value (US$ Mn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Hydrocephalus Valves
8.2.1.2. Hydrocephalus Catheters
8.2.1.3. Neuronavigation Systems
8.2.1.4. Others
8.3. Middle East & Africa Hydrocephalus Shunts Market Outlook, by Age Group, Value (US$ Mn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Paediatric
8.3.1.2. Adults
8.4. Middle East & Africa Hydrocephalus Shunts Market Outlook, by End User, Value (US$ Mn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Ambulatory Surgical Centers
8.4.1.3. Others
8.5. Middle East & Africa Hydrocephalus Shunts Market Outlook, by Country, Value (US$ Mn), 2019-2032
8.5.1. Key Highlights
8.5.1.1. GCC Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
8.5.1.2. GCC Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
8.5.1.3. GCC Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
8.5.1.4. GCC Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
8.5.1.5. South Africa Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
8.5.1.6. South Africa Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
8.5.1.7. South Africa Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
8.5.1.8. South Africa Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
8.5.1.9. Egypt Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
8.5.1.10. Egypt Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
8.5.1.11. Egypt Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
8.5.1.12. Egypt Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
8.5.1.13. Nigeria Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
8.5.1.14. Nigeria Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
8.5.1.15. Nigeria Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
8.5.1.16. Nigeria Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
8.5.1.17. Rest of Middle East & Africa Hydrocephalus Shunts Market by Type, Value (US$ Mn), 2019-2032
8.5.1.18. Rest of Middle East & Africa Hydrocephalus Shunts Market by Product, Value (US$ Mn), 2019-2032
8.5.1.19. Rest of Middle East & Africa Hydrocephalus Shunts Market by Age Group, Value (US$ Mn), 2019-2032
8.5.1.20. Rest of Middle East & Africa Hydrocephalus Shunts Market by End User, Value (US$ Mn), 2019-2032
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. by Age Group vs by Product Heatmap
9.2. Manufacturer vs by Product Heatmap
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. B. Braun Melsungen AG
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Sophysa
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. HpBio Próteses Inc.
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Integra Life Sciences Holdings Corporation
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Kaneka Medix Corporation
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Medtronic
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Natus Medical Incorporated
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Spiegelberg GmbH & Co. KG
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Desu Medical
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Natus Neuro
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations